Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Opposing the SAFE Banking Act.
Advocating for a prohibition on hemp-derived intoxicants.
Advocating against CCP-operating marijuana farms.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)